WSA appoints Marianne Vinding Ovesen as Chief Operating Officer
Lynge, December 2, 2024 – Marianne Vinding Ovesen has been appointed Chief Operating Officer and member of the Executive Committee, effective December 2, 2024. She succeeds Karl Braitberg, who resigned as COO to return to the USA with his family. Marianne Vinding Ovesen most recently served as COO of Beckman Coulter Diagnostics, a Danaher Corporation company serving the diagnostics and life sciences industries. Prior to Beckman Coulter Diagnostics, she led the operations division of Radiometer. Marianne began her career at Coloplast and is a Danish citizen. Jan Makela, WSA CEO, said: We thank Karl for his contributions to WSA and wish him well in his future endeavors. We are pleased to already announce his successor and welcome Marianne to the company and the Executive Committee. ### About WS Audiology Formed in 2019, through the merger of Sivantos and Widex, WS Audiology combines over 140 years’ experience in pioneering the use of technology to help people with hearing loss hear the sounds that make life wonderful. With truly differentiated brands like Widex, Signia, Rexton, Audio Service and Vibe, and with diverse assets across wholesale, retail, online, managed care and diagnostic solutions, we are active in over 130 markets. WS Audiology employs 12,500+ people and is privately owned by the Tøpholm and Westermann families and the Lundbeck Foundation, as well as funds under the management of EQT. As a global leader, our ambition is to unlock human potential by making wonderful sound part of everyone’s life.
Subscribe to releases from WS Audiology
Subscribe to all the latest releases from WS Audiology by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from WS Audiology
Carsten Buhl to leave WSA10.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 10, 2025 – WSA, a leading pure-play hearing healthcare group, today announced that Carsten Buhl, member of the Executive Committee and Executive Board of WSA, and President of its Americas Region, has decided to pursue a new career outside WSA and to leave the company on August 31, 2025. Carsten Buhl joined WSA in 2019, where he first served as President of the EMEA-LATAM-Canada region, next to being a member of WSA’s Group Management Team. In 2022 he was appointed President of the Americas Region. WSA CEO Jan Makela commented: We are sorry to see Carsten go and will certainly miss his constructive leadership style, as well as his deep insights into the hearing care market. We are happy for him as we part ways on positive terms. We are grateful for his many contributions to our company, and we wish him every success! Carsten Buhl said: “I am proud of my journey at WSA and what we have achieved together working with a fantastic group of highly motivated colleagues.
Dorothea Wenzel joins WSA’s Board of Directors and is appointed Chair of the Audit Committee2.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 2, 2025 – WSA, a leading pure-play hearing healthcare group, is pleased to announce that Dorothea Wenzel has joined its Board of Directors and has been appointed Chair of the Audit Committee, effective immediately. At the same time, Julian Tøpholm is stepping down from the Board. Ms. Wenzel joins as an independent director with an impressive track record in finance and strategy leadership across multiple industries, including a long career at the biopharmaceutical company Merck, where she held several commercial and financial executive positions. She has extensive experience in leading business transformations, and significant board experience from Dentsply Sirona Inc., Servier Group, Gerresheimer, and as Lead Independent Director at Fresenius Medical Care AG & Co. Most recently, she was appointed Chair of Lundbeck, following her tenure as Chair of its Audit Committee. WSA Chair Lars Rasmussen commented: We are delighted to welcome Dorothea to the WSA Board. Her br
WSA delivered 1% organic revenue growth and increased EBITDA by 22% in the second quarter of FY 2024/258.5.2025 00:00:00 CEST | Press release
Lynge, Denmark – May 8, 2025 – WSA, a leading pure-play hearing healthcare group, today announced results for the second quarter of the financial year 2024/25 (January 1, 2025 – March 31, 2025) showing organic revenue growth of 1% and an increase in EBITDA of 22%, corresponding to an EBITDA margin improvement of 2.8%-points. Jan Mäkelä, CEO of WSA, said: With an organic revenue growth of 1% in a volatile macro environment and a significant EBITDA margin improvement, WSA delivered satisfactory second quarter results. I am very pleased with the successful launch of Signia BCT IX and Widex Allure at the end of the quarter. With our complementary and distinct Signia and Widex brand platforms, we are committed to delivering an uncompromising hearing experience that meets the unique needs of the largest groups of people with hearing loss and the hearing care professionals serving them.” Highlights Q2 2024/2025 (Q2 last financial year in brackets) WSA delivered organic revenue growth of 1% (7
WS Audiology Expands Indian Operations with New Commercial and Production Hub in Bangalore16.4.2025 00:00:00 CEST | Press release
Bangalore, India – 16 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced the opening of its new office in Bangalore, further strengthening its footprint in India. The facility, operating as WS Audiology India, will serve as a key hub for commercial and production activities, supporting WSA’s long-term commitment to improve hearing health access across the country. The new Bangalore office reflects WSA’s belief in India’s growing role in the global hearing care landscape. According to the World Health Organization, an estimated 6.3% of India’s population suffers from significant hearing loss. WSA continues to lead the industry in making hearing care more accessible, affordable, and effective through its “Triple A” approach—Awareness, Affordability, and Accessibility. Supporting Growth, Enhancing Service “India has been one of our fastest-growing markets in APAC, and we’re incredibly proud of the work our teams have done here,” said Avinash Pa
WSA welcomes ATHOS KG as a new shareholder and receives new investment to support its long-term development11.4.2025 00:00:00 CEST | Press release
Lynge, Denmark – 11 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced ATHOS KG as a new minority shareholder, as well as an equity capital injection of EUR c. 590 million in total from its existing and new shareholders to further support the company’s successful growth trajectory and long-term strategic ambitions. WSA welcomes ATHOS, a German healthcare focused single family office, as a new shareholder alongside T&W Medical, EQT, and the Lundbeck Foundation, which together continue to exercise joint control of WSA in an unchanged governance set-up. Lars Rasmussen, Chair of WSA, said: I am pleased by the strong commitment of WSA’s shareholders to the company’s continued growth and long-term development. The owners have decided to strengthen WSA’s financial foundation by injecting equity, which will further bring down WSA’s net leverage. At the same time, I am pleased to welcome ATHOS as a shareholder of WSA. With T&W Medical, EQT, the Lundb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom